A team of researchers has profiled in unprecedented detail thousands of individual cells sampled from patients’ brain tumors. The findings, along with the methods developed to obtain those findings, represent a significant advance in cancer research.
On Sept. 24, after a year highlighted by so many virtual events, the Class of 2024 finally celebrated their medical school journey with a White Coat Ceremony – hosted in-person.
In this Q&A, Dr. Roy Gulick of Weill Cornell Medicine breaks down the science underlying booster shots of COVID-19 vaccines and answers some frequently asked questions.
Malignant tumors can enhance their ability to survive and spread by suppressing antitumor immune cells in their vicinity, but a new study has uncovered a way to counter this effect.
The newly launched Cornell Jeb E. Brooks School of Public Policy will help shape a better world, university leaders and the school’s inaugural dean said at a Sept. 15 reception in Martha Van Rensselaer Hall.
Paula Cohen, associate vice provost for life sciences, is leading an eight-year, $8 million, multi-institution grant to untangle the complex genetic rulebook for how sperm develops.
The National Institutes of Health has awarded a $26.5 million grant to a group that includes Weill Cornell Medicine, which aims to both silence and permanently remove HIV from the body.
A team including researchers from Weill Cornell Medicine has received a five-year, $12.8 million grant from the National Heart, Lung, and Blood Institute to validate discoveries that may provide answers about lung diseases.
A cellular protein whose normal function appears to suppress bone formation may be a potential new target for treating osteoporosis, according to a collaborative study led by Weill Cornell Medicine and NewYork-Presbyterian researchers.
